Want to free Internet? Do philanthropy: Mittal to Zuckerberg

March 9, 2015

Barcelona, Mar 9: Taking on social networking giant Facebook's ambitious 'free internet' plans, telecom major Bharti Airtel chief Sunil Mittal has said the companies should do 'philanthropy' if they stop charging for mobile internet.

Mittal ZuckerbergFacebook has launched an 'internet.org' initiative under which users can access internet free of charge for select websites if they come through a partner telecom operator.

Incidentally, Airtel Africa is one such partner for Facebook, while rival Reliance Communications has partnered Facebook in India for this initiative, which is based on assumption that bringing more people to the internet fold by offering them free service initially is good for the industry.

Mittal, who met Facebook founder and CEO Mark Zuckerberg here at the Mobile World Congress, said that the social networking major is right in its thinking that such a would expand the market, but telecom operators also need to get their revenues and charge for the services.

"I told him (Zuckerberg) that you are right that this (internet.org) expands the market. At the end, you must understand that we (telecom operators) need to charge you for something. SMSes have gone more or less, voice is going down and they (Facebook) recognise that," Mittal said in a media interaction here.

"If you are going to make the data free, then let's do completely philanthropic projects. Government must make spectrum free, there should be free network, but it is not happening," the billionaire industrialist said, while adding that telecom companies were as such not making large money.

The comments, incidentally, come at a time when a high-pitched auction is underway in India for spectrum and committed bids worth about Rs 86,000 crore have come in within first four days of bidding -- crossing the minimum targetted amount of Rs 82,000 crore. The auction will resume tomorrow, as more unsold spectrum is left and there are expectations that the overall auction may cross Rs one lakh crore.

Telecom companies say they invest billions of dollars in spectrum, network and other operations, but they argue that internet-based entities offering pseudo-telecom services are piggy-backing on the mobile operators' networks without bearing much investments on their own.

At the same event here, UK-based telecom giant Vodafone's global CEO Vittorio Colao reportedly said about Facebook's free-of-cost internet plan that "it is almost like Zuckerberg does philanthropy, but with my money."

Mittal cautioned that investments in mobile networks by industry will go down as Internet-based messaging and calling services are 'cannibalising' revenues of telecom firms.

"He (Zuckerberg) is saying that make Internet.org lite version of Facebook free of data charge, so that people will upgrade. People will come to internet for the first time. The point is that it is self-serving for them," Mittal said.

Telecom operators have been facing pressure on their financials from the emergence of a number of Over-The-Top (OTT) firms like Facebook (through its WhatsApp messaging service), Skype and Viber, which on their part claim to be helping telecom operators grow business.

"We (telecom operators, social media and over-the-top players) are good for each other but they, regulators and politicians must understand that networks' investment must be on reasonable terms. Gone are the days when telecom companies were making large amounts of money," Mittal said.

"OTT players must understand pains of the mobile industry. Sometimes we are seeing as gatekeeper, bad guys. The fact of matter is spectrum - there is cost, network there is cost and tariff has gone up by only 3 paise in last three years," he added.

In December, Airtel had announced separate charges for Internet based calling services but withdrew it after an outcry on social media.

"The rate that we announced was exactly the same rate as a voice call. If you do one minute VoIP (internet based calls) in kilobyte terms it would be exactly the same as voice call. It was exactly the same as one minute call," Mittal said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 31,2020

Washington, May 31: US President Donald Trump said Saturday he will delay the G7 summit scheduled to take place in June and invite other countries -- including India and Russia -- to join the meeting.

"I don't feel that as a G7 it properly represents what's going on in the world. It's a very outdated group of countries," Trump told reporters on Air Force One.

He said he would like to invite Russia, South Korea, Australia and India to join an expanded summit in the fall.

It could happen in September, either before or after the UN General Assembly, Trump said, adding that "maybe I'll do it after the election."

Americans head to the polls in early November to choose a new president, with Trump keen for a return to normalcy after the coronavirus pandemic and a healthy economy as voters cast their ballots.

Describing the event as a "G-10 or G-11", Trump said he had "roughly" broached the topic with leaders of the four other countries.

Leaders from the Group of Seven, which the United States heads this year, had been scheduled to meet by videoconference in late June after COVID-19 scuttled plans to gather in-person at Camp David, the US presidential retreat outside Washington.

Trump created suspense last week, however, when he announced that he might hold the huge gathering in-person after all, "primarily at the White House" but also potentially parts of it at Camp David.

German Chancellor Angela Merkel became the first leader to decline the in-person invitation outright.

"Considering the overall pandemic situation, she cannot agree to her personal participation, to a journey to Washington," her spokesman said Saturday.

Her response followed ambivalent to positive reactions to the invitation from Britain, Canada and France.

The 65-year-old chancellor is the oldest G7 leader after Trump, who is 73. Japan's Shinzo Abe, also 65, is several months younger than Merkel. Their age puts them at higher risk from the coronavirus.

The G7 major advanced countries -- Britain, Canada, France, Germany, Italy, Japan and the United States -- hold annual meetings to discuss international economic coordination.

Russia was thrown out of what was the G8 in 2014 after it seized Ukraine's Black Sea peninsula of Crimea, an annexation never recognized by the international community.

The work of the G7 is now more important than ever as countries struggle to repair coronavirus-inflicted damage.

The White House had previously said the huge diplomatic gathering would be a "show of strength" when world economies are gradually reemerging from shutdowns.

The United States is the worst-hit country for COVID-19 infections, recording more than 1.7 million cases and over 103,680 deaths.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 2,2020

Minneapolis, Jun 2: An official autopsy released Monday ruled that George Floyd, the African-American man whose death at police hands set off unrest across the United States, died in a homicide involving "neck compression".

George, 46, died of "cardiopulmonary arrest complicating law enforcement subdual, restraint, and neck compression," and the manner of death was "homicide," the Hennepin County Medical Examiner in Minneapolis said in a statement.

Floyd's other significant health conditions were listed as "arteriosclerotic and hypertensive heart disease; fentanyl intoxication; recent methamphetamine use."

The statement added that the "manner of death is not a legal determination of culpability or intent."

It emphasized that under Minnesota state law "the Medical Examiner is a neutral and independent office and is separate and distinct from any prosecutorial authority or law enforcement agency."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.